Clinical Trial

Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)

Study acronym: GP
Recruiting
View on ClinicalTrials.gov →
Summary
The purposes of this study are: * to determine if there are specific genetic traits that might explain why patients have developed pulmonary fibrosis; * to determine if specific genetic traits account for differing patterns of inflammation and scar tissue that has formed in the patient's lungs.
Protocol Amendment History 21 amendments
This ClinicalTrials.gov record has been amended 21 times since 2005-11-23; most recent amendment 2025-11-11.
Status change: Active, Not Recruiting → Recruiting 2023-08-18
Status change: Recruiting → Active, Not Recruiting 2022-12-13
Trial Details
NCT Number NCT00258570
Lead Sponsor University of Pittsburgh
Conditions Pulmonary Fibrosis
Enrollment 2,000 participants
Start Date 2003-01
Primary Completion 2035-07 (estimated)
Study Completion 2035-07 (estimated)
Updated on ClinicalTrials.gov 2025-11-12